Homovanillic acidCatecholamine metabolite CAS# 306-08-1 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 306-08-1 | SDF | Download SDF |
PubChem ID | 1738 | Appearance | Powder |
Formula | C9H10O4 | M.Wt | 182.17 |
Type of Compound | Phenols | Storage | Desiccate at -20°C |
Synonyms | HVA | ||
Solubility | Soluble to 50 mM in water and to 100 mM in DMSO | ||
Chemical Name | 2-(4-hydroxy-3-methoxyphenyl)acetic acid | ||
SMILES | COC1=C(C=CC(=C1)CC(=O)O)O | ||
Standard InChIKey | QRMZSPFSDQBLIX-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C9H10O4/c1-13-8-4-6(5-9(11)12)2-3-7(8)10/h2-4,10H,5H2,1H3,(H,11,12) | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Homovanillic acid is used as a reagent to detect oxidative enzymes, and is associated with dopamine levels in the brain. Abnormalities in white matter were associated with low CSF Homovanillic acid. |
In vitro | Analysis of vanillylmandelic acid and homovanillic acid by UPLC-MS/MS in serum for diagnostic testing for neuroblastoma.[Pubmed: 23830883]Clin Chim Acta. 2013 Sep 23;424:253-7.Vanillylmandelic acid (VMA) and Homovanillic acid (HVA) are typically measured in urine for the diagnosis and monitoring of neuroblastoma, a tumor in children <5 y. A protocol for evaluation of serum VMA and Homovanillic acid has been utilized at our institution for approximately 25 y, originally validated using high performance liquid chromatography (HPLC) with an electrochemical detector.
We recently validated a serum VMA/HVA method by ultra performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). |
In vivo | Homovanillic acid in cerebrospinal fluid of 1388 children with neurological disorders.[Pubmed: 23480488]Dev Med Child Neurol. 2013 Jun;55(6):559-66.To determine the prevalence of dopaminergic abnormalities in 1388 children with neurological disorders, and to analyse their clinical, neuroradiological, and electrophysiological characteristics.
|
Structure Identification | Spectrochim Acta A Mol Biomol Spectrosc. 2014 Jan 24;118:1068-74.Molecular structure and spectroscopic analysis of homovanillic acid and its sodium salt--NMR, FT-IR and DFT studies.[Pubmed: 24161870]The estimation of the electronic charge distribution in metal complex or salt allows to predict what kind of deformation of the electronic system of ligand would undergo during complexation. It also permits to make more precise interpretation of mechanism by which metals affect the biochemical properties of ligands.
|
Homovanillic acid Dilution Calculator
Homovanillic acid Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 5.4894 mL | 27.4469 mL | 54.8938 mL | 109.7876 mL | 137.2345 mL |
5 mM | 1.0979 mL | 5.4894 mL | 10.9788 mL | 21.9575 mL | 27.4469 mL |
10 mM | 0.5489 mL | 2.7447 mL | 5.4894 mL | 10.9788 mL | 13.7234 mL |
50 mM | 0.1098 mL | 0.5489 mL | 1.0979 mL | 2.1958 mL | 2.7447 mL |
100 mM | 0.0549 mL | 0.2745 mL | 0.5489 mL | 1.0979 mL | 1.3723 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- SC 79
Catalog No.:BCC6246
CAS No.:305834-79-1
- 3,9-Bis(2-cyanoethyl)-2,4,8,10-tetraoxaspiro[5.5]undecane
Catalog No.:BCC8599
CAS No.:3058-04-6
- H-Asp(OtBu)-OH
Catalog No.:BCC2891
CAS No.:3057-74-7
- Geldanamycin
Catalog No.:BCC2125
CAS No.:30562-34-6
- Acephate
Catalog No.:BCC7555
CAS No.:30560-19-1
- Stavudine (d4T)
Catalog No.:BCC5028
CAS No.:3056-17-5
- Bisabolangelone
Catalog No.:BCN8094
CAS No.:30557-81-4
- Etofenamate
Catalog No.:BCC1563
CAS No.:30544-47-9
- H-Cys(Bzl)-OH
Catalog No.:BCC2906
CAS No.:3054-01-1
- 5'-Demethylaquillochin
Catalog No.:BCN5221
CAS No.:305364-91-4
- Caulilexin C
Catalog No.:BCN3960
CAS No.:30536-48-2
- SL-327
Catalog No.:BCC1123
CAS No.:305350-87-2
- Spermine tetrahydrochloride
Catalog No.:BCC6864
CAS No.:306-67-2
- 2,2-Diphenylglycine
Catalog No.:BCC8496
CAS No.:3060-50-2
- AVE 0991 sodium salt
Catalog No.:BCC4222
CAS No.:306288-04-0
- (20S)-Protopanaxdiol
Catalog No.:BCN1254
CAS No.:30636-90-9
- Cycloolivil
Catalog No.:BCN4081
CAS No.:3064-05-9
- 5-Methoxy-7-hydroxycoumarin
Catalog No.:BCN3538
CAS No.:3067-10-5
- TCID
Catalog No.:BCC4449
CAS No.:30675-13-9
- IBC 293
Catalog No.:BCC7376
CAS No.:306935-41-1
- GW-1100
Catalog No.:BCC1610
CAS No.:306974-70-9
- CL 82198 hydrochloride
Catalog No.:BCC2372
CAS No.:307002-71-7
- WAY 170523
Catalog No.:BCC2380
CAS No.:307002-73-9
- 1,4-Bis[2-(4-methyl-5-phenyloxazolyl)]benzene
Catalog No.:BCC8425
CAS No.:3073-87-8
Interchangeability between 24-hour collection and single spot urines for vanillylmandelic and homovanillic acid levels in the diagnosis of neuroblastoma.[Pubmed:23813598]
Pediatr Blood Cancer. 2013 Dec;60(12):E170-2.
The determination of the two urinary catecholamine metabolites Homovanillic acid (HVA) and vanillylmandelic acid (VMA) is of crucial importance for the diagnosis and follow-up of neuroblastoma (NB). The standard practice for their measurement requires the use of 24-hour collections that are time consuming and difficult to obtain. In this article, we directly demonstrate that 24-hour collections and single spot urines are interchangeable for the determination of HVA and VMA expressed as ratio on creatinine concentration. This study can be useful for a faster management of NB at onset.
Analysis of vanillylmandelic acid and homovanillic acid by UPLC-MS/MS in serum for diagnostic testing for neuroblastoma.[Pubmed:23830883]
Clin Chim Acta. 2013 Sep 23;424:253-7.
BACKGROUND: Vanillylmandelic acid (VMA) and Homovanillic acid (HVA) are typically measured in urine for the diagnosis and monitoring of neuroblastoma, a tumor in children <5 y. A protocol for evaluation of serum VMA and HVA has been utilized at our institution for approximately 25 y, originally validated using high performance liquid chromatography (HPLC) with an electrochemical detector. We recently validated a serum VMA/HVA method by ultra performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). METHODS: After solvent extraction and clean up with Ultrafree centrifugal filters, samples were analyzed by UPLC-MS/MS in multiple reaction monitoring mode. RESULTS: The assay was linear between 2 and 1000 ng/ml for VMA and HVA. Within run and run to run CVs were <5% for VMA at all levels, <10% for HVA at high levels, and <20% at low levels. Correlation with the HPLC method was acceptable with a constant bias. The reference interval for VMA by UPLC-MS/MS was determined to be =20 ng/ml, and HVA=30 ng/ml. Original patient data comparing urine to serum showed diagnostic agreement >80% for both VMA and HVA. CONCLUSION: Correlation of VMA and HVA was acceptable after adjustment of reference intervals. Collection of a single serum sample instead of 24-h urine collection saves time and improves accuracy of measurement due to difficulty of collecting a 24-h urine sample in infants and young children. UPLC-MS/MS also offers improved analyte specificity, improved signal to noise, and rapid analysis time.
Homovanillic acid in cerebrospinal fluid of 1388 children with neurological disorders.[Pubmed:23480488]
Dev Med Child Neurol. 2013 Jun;55(6):559-66.
AIM: To determine the prevalence of dopaminergic abnormalities in 1388 children with neurological disorders, and to analyse their clinical, neuroradiological, and electrophysiological characteristics. METHOD: We studied biogenic amines in 1388 cerebrospinal fluid (CSF) samples from children with neurological disorders (mean age 3y 10mo, SD 4y 5mo; 712 males, 676 females. Correlations among CSF Homovanillic acid (HVA) values and other biochemical, clinical, neuroradiological, and electrophysiological parameters were analysed. RESULTS: Twenty-one patients with primary dopaminergic deficiencies were identified. Of the whole sample, 20% showed altered HVA. We report neurological diseases with abnormal CSF HVA values such as pontocerebellar hypoplasia, perinatal asphyxia, central nervous system infections, mitochondrial disorders, and other genetic diseases. Overlapping HVA levels between primary and secondary dopamine deficiencies were observed. Prevalence of low CSF HVA levels was significantly higher in neonatal patients (chi(2) =84.8, p<0.001). Abnormalities in white matter were associated with low CSF HVA (odds ratio 2.3, 95% confidence interval 1.5-3.5). INTERPRETATION: HVA abnormalities are observed in various neurological diseases, but some are probably an unspecific finding. No clear limits for CSF HVA values pointing towards primary diseases can be stated. We report several neurological diseases showing HVA alterations. No neuroimaging traits were associated with low HVA values, except for white matter abnormalities.
Molecular structure and spectroscopic analysis of homovanillic acid and its sodium salt--NMR, FT-IR and DFT studies.[Pubmed:24161870]
Spectrochim Acta A Mol Biomol Spectrosc. 2014 Jan 24;118:1068-74.
The estimation of the electronic charge distribution in metal complex or salt allows to predict what kind of deformation of the electronic system of ligand would undergo during complexation. It also permits to make more precise interpretation of mechanism by which metals affect the biochemical properties of ligands. Theinfluence ofsodium cation on the electronic system of Homovanillic acid was studied in this paper. Optimized geometrical structures of studied compounds were calculated by B3LYP/6-311++G(**) method. Mulliken, MK and ChelpG atomic charges were analyzed. The theoretical NMR and IR spectra were obtained. (1)H and (13)C NMR as well as FT-IR and FT-Raman spectra of studied compounds were also recorded and analyzed. The calculated parameters are compared with experimental characteristics of these molecules.